New York S 1862: Relates to synthetic cannabinoid

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S01862 Summary:

BILL NOS01862 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORMYRIE

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add §392-k, Gen Bus L

&nbsp

Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraudulent replacement, packaging, and labeling of such drugs; provides for better consumer protection.

Go to top S01862 Actions:

BILL NOS01862 

&nbsp

01/14/2025REFERRED TO CONSUMER PROTECTION

01/07/2026REFERRED TO CONSUMER PROTECTION

Go to topS01862 Committee&nbspVotes:

Go to topS01862 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS01862 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 1862

 2025-2026 Regular Sessions

 IN SENATE

 January 14, 2025
 ___________

 Introduced by Sen. MYRIE -- read twice and ordered printed, and when
 printed to be committed to the Committee on Consumer Protection

 AN ACT to amend the general business law, in relation to preserving the
 integrity and safety of pharmaceutical drugs

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The general business law is amended by adding a new section
 2 392-k to read as follows:
 3 § 392-k. False labels and misrepresentations of pharmaceutical drugs.
 4 1. A person, who with intent to defraud:
 5 a. Puts upon a pharmaceutical drug, or upon a cask, bottle, stopper,
 6 vessel, case, cover, wrapper, package, band, ticket, label or other
 7 thing, containing or covering such pharmaceutical drug, or with which
 8 such a pharmaceutical drug is intended to be sold, or is sold, any false
 9 description or other indication of or respecting the type of pharmaceu-
 10 tical substance or compound, kind, number, quantity, weight or measure
 11 of such substance, or any part thereof, or the place or country where it
 12 was manufactured or produced or the quality or grade of any such
 13 substance, if the quality or grade thereof is required by law to be
 14 marked, branded or otherwise indicated on or with such pharmaceutical
 15 drug; or
 16 b. Sells or offers for sale a pharmaceutical drug, which to such
 17 person's knowledge is falsely described or indicated upon any such pack-
 18 age, or vessel containing the same, or label thereupon, in any of the
 19 particulars specified; or
 20 c. Distributes, sells or exposes for sale any goods in bulk to which
 21 no name or trademark shall be attached, and orally or otherwise repres-
 22 ents that such pharmaceutical drugs are the manufacture or production of
 23 some other than the actual manufacturer or producer; or
 24 d. Removes or conceals or who shall cause to be, wholly or in part,
 25 removed or concealed from or upon a pharmaceutical drug the mark of

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD05414-01-5

 S. 1862 2

 1 origin; or who sells or causes to be sold an article of merchandise from
 2 or upon which to such person's or its knowledge, or to the knowledge of
 3 such person's or its agents, servants or employees there has been in
 4 whole or in part, removed or concealed the mark of origin, or who sells
 5 or causes to be sold a pharmaceutical drug from the inspection of which
 6 such knowledge could have been obtained, shall be guilty of a misdemea-
 7 nor, provided that it shall not be deemed a violation of this section if
 8 at the time of sale said article of merchandise and the immediate and
 9 outer container or containers thereof shall be marked, stamped, tagged,
 10 branded or labeled in legible and conspicuous English words with said
 11 mark of origin or the concealment thereof shall have completely ceased,
 12 in a case where the punishment for such offense is not specially
 13 provided for otherwise by statute, is guilty of a misdemeanor.
 14 2. For the purposes of this section, the following words shall have
 15 the following definitions:
 16 a. "Person" shall be deemed to include a firm, partnership, associ-
 17 ation or corporation.
 18 b. "Sell" shall be deemed to include offer to sell, expose for sale,
 19 and possess with intent to dispose of or to sell.
 20 c. "Pharmaceutical drug" shall be deemed to include a cask, bottle,
 21 stopper, v